Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints.
AnticoagulantsThromboseEfficacité du traitement
#3
Le traitement est-il à vie ?
Pas toujours, mais de nombreux patients nécessitent un traitement à long terme.
Traitement à long termeSyndrome des anticorps antiphospholipidesAnticoagulants
#4
Y a-t-il des effets secondaires aux traitements ?
Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables.
Effets secondairesAnticoagulantsSaignements
#5
Les femmes enceintes peuvent-elles être traitées ?
Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse.
GrossesseHéparineAnticoagulants
Complications
5
#1
Quelles sont les complications possibles du syndrome ?
Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches.
ThrombosesAVCFausses couches
#2
Le syndrome peut-il causer des problèmes cardiaques ?
Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus.
Maladies cardiovasculairesInfarctusSyndrome des anticorps antiphospholipides
#3
Y a-t-il des risques pour la santé mentale ?
Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients.
Santé mentaleTroubles anxieuxDépression
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables.
ComplicationsGestionEffets durables
#5
Le syndrome augmente-t-il le risque de cancer ?
Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires.
CancerSyndrome des anticorps antiphospholipidesRecherche
Facteurs de risque
5
#1
Quels sont les facteurs de risque du syndrome ?
Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections.
Facteurs de risqueMaladies auto-immunesInfections
#2
Le sexe influence-t-il le risque ?
Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans.
SexeFemmesSyndrome des anticorps antiphospholipides
#3
Les antécédents de thromboses augmentent-ils le risque ?
Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome.
Antécédents médicauxThromboseSyndrome des anticorps antiphospholipides
#4
Les infections virales sont-elles un facteur de risque ?
Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome.
Infections viralesVIHFacteurs de risque
#5
Le tabagisme influence-t-il le risque ?
Oui, le tabagisme est associé à un risque accru de thromboses et de complications.
TabagismeThromboseFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome des anticorps antiphospholipides : Questions médicales les plus fréquentes",
"headline": "Syndrome des anticorps antiphospholipides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome des anticorps antiphospholipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes",
"url": "https://questionsmedicales.fr/mesh/D001327",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes",
"code": {
"@type": "MedicalCode",
"code": "D001327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides",
"alternateName": "Antiphospholipid Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D016736",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Doruk Erkan",
"url": "https://questionsmedicales.fr/author/Doruk%20Erkan",
"affiliation": {
"@type": "Organization",
"name": "Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, and Weill Cornell Medicine, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Hannah Cohen",
"url": "https://questionsmedicales.fr/author/Hannah%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK."
}
},
{
"@type": "Person",
"name": "Imad Uthman",
"url": "https://questionsmedicales.fr/author/Imad%20Uthman",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon."
}
},
{
"@type": "Person",
"name": "Katrien M J Devreese",
"url": "https://questionsmedicales.fr/author/Katrien%20M%20J%20Devreese",
"affiliation": {
"@type": "Organization",
"name": "Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium."
}
},
{
"@type": "Person",
"name": "Yu Zuo",
"url": "https://questionsmedicales.fr/author/Yu%20Zuo",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Obtaining blood components in blood banks].",
"datePublished": "2023-01-01",
"url": "https://questionsmedicales.fr/article/36378143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of the treatment volume and removal rate of Rheocarna: A novel adsorption-type blood purification device for patients with chronic limb-threatening ischemia.",
"datePublished": "2023-08-17",
"url": "https://questionsmedicales.fr/article/37589198",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1744-9987.14050"
}
},
{
"@type": "ScholarlyArticle",
"name": "Magnetic blood purification-based soluble fms-like tyrosine kinase-1 removal in comparison with dextran sulfate apheresis and therapeutic plasma exchange.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/36995348",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/aor.14531"
}
},
{
"@type": "ScholarlyArticle",
"name": "A rare vascular injury in a blood donor after whole blood donation.",
"datePublished": "2024-01-17",
"url": "https://questionsmedicales.fr/article/38230511",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/trf.17725"
}
},
{
"@type": "ScholarlyArticle",
"name": "State of the Evidence: Drug Removal via Apheresis.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36604194",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tmrv.2022.12.003"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndrome des anticorps antiphospholipides",
"item": "https://questionsmedicales.fr/mesh/D016736"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome des anticorps antiphospholipides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome des anticorps antiphospholipides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome des anticorps antiphospholipides",
"description": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe diagnostic nécessite-t-il des symptômes cliniques ?\nPeut-on avoir le syndrome sans symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Blood+Component+Removal#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les symptômes courants du syndrome ?\nLe syndrome peut-il causer des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLe syndrome affecte-t-il la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Blood+Component+Removal#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome des anticorps antiphospholipides",
"description": "Comment prévenir les complications du syndrome ?\nY a-t-il des changements de mode de vie recommandés ?\nLes femmes enceintes doivent-elles être surveillées ?\nLes vaccinations sont-elles importantes ?\nLe stress a-t-il un impact sur le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Blood+Component+Removal#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome des anticorps antiphospholipides",
"description": "Quels traitements sont disponibles pour le syndrome ?\nLes anticoagulants sont-ils efficaces ?\nLe traitement est-il à vie ?\nY a-t-il des effets secondaires aux traitements ?\nLes femmes enceintes peuvent-elles être traitées ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Blood+Component+Removal#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome des anticorps antiphospholipides",
"description": "Quelles sont les complications possibles du syndrome ?\nLe syndrome peut-il causer des problèmes cardiaques ?\nY a-t-il des risques pour la santé mentale ?\nLes complications sont-elles réversibles ?\nLe syndrome augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Blood+Component+Removal#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les facteurs de risque du syndrome ?\nLe sexe influence-t-il le risque ?\nLes antécédents de thromboses augmentent-ils le risque ?\nLes infections virales sont-elles un facteur de risque ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Blood+Component+Removal#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps antiphospholipides."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le lupus anticoagulant, les anticorps anti-cardiolipine et anti-bêta-2-glycoprotéine I."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents de thromboses et la présence d'anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il des symptômes cliniques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de thromboses ou de complications obstétricales sont souvent requis."
}
},
{
"@type": "Question",
"name": "Peut-on avoir le syndrome sans symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent avoir des anticorps sans présenter de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des thromboses, des fausses couches et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de thromboses dans les vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des maux de tête, des AVC ou des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Le syndrome affecte-t-il la grossesse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des complications comme des fausses couches ou des prééclampsies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du syndrome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la prise régulière d'anticoagulants et le suivi médical."
}
},
{
"@type": "Question",
"name": "Y a-t-il des changements de mode de vie recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé, faire de l'exercice et éviter le tabac sont conseillés."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance étroite est essentielle pour prévenir les complications obstétricales."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent le syndrome."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le syndrome ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, donc des techniques de gestion du stress sont utiles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à vie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais de nombreux patients nécessitent un traitement à long terme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles être traitées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables."
}
},
{
"@type": "Question",
"name": "Le syndrome augmente-t-il le risque de cancer ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du syndrome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents de thromboses augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de thromboses et de complications."
}
}
]
}
]
}
Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano-Istituto di Ricovero e Cura a Carattere Scientifico, Milano, Italy.
Publications dans "Syndrome des anticorps antiphospholipides" :
Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Spain.
Publications dans "Syndrome des anticorps antiphospholipides" :
Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Aosta Valley Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy; Nephrology and Dialysis, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Italy.
Publications dans "Syndrome des anticorps antiphospholipides" :
Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Aosta Valley Network for Rare Diseases, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, University of Turin, Italy; Nephrology and Dialysis, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Italy. Electronic address: savino.sciascia@unito.it.
Publications dans "Syndrome des anticorps antiphospholipides" :
Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Publications dans "Syndrome des anticorps antiphospholipides" :
Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Publications dans "Syndrome des anticorps antiphospholipides" :
After the first successful blood transfusion, different difficulties of a liquid tissue were overcome; this liquid required special conditions to keep its characteristics with minimal alterations and,...
Chronic limb-threatening ischemia (CLTI) is a clinical syndrome defined by peripheral arterial disease (PAD) combined with rest pain, gangrene, or leg ulceration for longer than two weeks resulting in...
To evaluate the applicability of this treatment procedure, we compared the removal rates of Fib and LDL following Rheocarna therapy using various blood treatment volumes (6, 10.5, and 19.5 L)....
Fib and LDL removal rates were about 20% and 15%-25% per treatment, with no significant differences between treatment volumes. Following treatment with Rheocarna, blood pressure tends to decrease at f...
Although no significant difference was found in the removal rate of Fib and LDL in response to increase volume to 6 L or beyond in this study, the 6 L volume is considered effective enough for the rem...
Preeclampsia remains one of the most serious complications of pregnancy. Effective therapies are yet to be developed. Recent research has identified an imbalance of angiogenic and antiangiogenic facto...
We compare the performance and selectivity of TPE, DSA, and MBP for the therapeutic removal of sFlt-1. For MPB, we employ magnetic nanoparticles functionalized with either sFlt-1 antibodies or the sFl...
We demonstrate that sFlt-1 removal by MBP is feasible and significantly more selective than TPE and DSA at comparable sFlt-1 removal efficiencies (MBP 96%, TPE 92%, DSA 78%). During both TPE and DSA, ...
Taken together, the highly selective removal of sFlt-1 and potential other disease-causing factors by extracorporeal magnetic blood purification may offer new prospects for preeclamptic patients....
Blood donation is a safe process though reactions may still occur. We describe a rare vascular complication in a frequent donor, with improvements in the collection process aimed at avoiding future ev...
A 63-year-old woman presented with local pain and an apparent collection in the left arm 8 days after donation. Duplex ultrasound identified a superficial liquid collection and signs of arteriovenous ...
Investigation showed a faster whole blood bag collection time (3 min; normal: 5-9 min), and the processed packed red blood cell had a brighter red color than usual. The donor reported local bleeding a...
We described an uncommon AP in a donor that was not identified, leading to an AVF that spontaneously thrombosed....
Therapeutic apheresis refers to a diversity of procedures in which specific hematologic components (e.g., plasma, erythrocytes, leukocytes, etc.) with pathological associations are removed from circul...
Currently greater than 94% of the US platelet supply is collected by apheresis. A survey to determine the attitudes of members of America's Blood Centers (ABC) toward whole blood derived (WBD) platele...
An on-line survey was distributed to medical directors of the 47 ABC members....
Responses were received from 44/47 (94%) ABC members. There were 15/43 (35%) centers that are currently providing WBD platelets. Seventy percent of the respondents agreed or agreed strongly that WBD a...
The majority of blood collectors consider WBD platelets clinically equivalent to apheresis, however wider adoption of WBD platelets is still hindered by challenges with logistics and inventory managem...
Pediatric apheresis collection of peripheral blood stem cells for autologous transplantation often requires use of a blood prime. We evaluated the relationship between pre-apheresis blood CD34...
The demand for blood products sometimes exceeds the available inventory. Blood product inventories are dependent upon the availability of donors, supplies and reagents, and collection staff. During pr...
The Association for the Advancement of Blood and Biotherapies Donor and Blood Component Management Subsection compiled some strategies from its blood center and hospital transfusion service members th...
Some strategies that blood centers could use to increase their available inventories include increasing donor recruitment efforts, using alternate types of collection kits, manufacturing low-yield aph...
Blood centers and transfusion services must choose the appropriate strategies to implement based on their needs....
Enabling universal access to safe blood components should be a key component of every country's national healthcare strategy. This study aimed to assess the current status of infrastructure and resour...
A cross-sectional survey was designed to gather information on blood donations, components, redistribution, testing resources and quality management systems (QMSs). The survey was distributed to the I...
A total of 54 respondents from 20 countries responded to the survey. This included hospital-based BTS/blood centres (46%), national blood centres (11%)and national and regional blood services (11%). V...
QMS was implemented in most of the countries despite the common use of paid donations and the lack of advanced testing. Efforts to overcome persistent challenges and wider implementation of patient bl...
Salvia miltiorrhiza Bunge (SM) is an outstanding herbal medicine with various traditional effects, especially promoting blood circulation to remove blood stasis. It has been widely used for centuries ...
To summarize the bioactive components of SM against BSS and highlight its potential targets and signaling pathways, hoping to provide a modern biomedical perspective to understand the efficacy of SM o...
A comprehensive literature search was performed to retrieve articles published in the last two decades on bioactive components of SM used for BSS treatment from the online electronic medical literatur...
Phenolic acids and tanshinones in SM are the main bioactive components in the treatment of BSS, including but not limited to salvianolic acid B, tanshinone IIA, salvianolic acid A, cryptotanshinone, D...
Both phenolic acids and tanshinones in SM may act synergistically to target different signaling pathways to achieve the effect of promoting blood circulation....